Loss of response to azacitidine is associated with deletion 12p13 in a patient with myelodysplastic syndrome with unique translocation t(13;17)(q12;q25) after prior breast cancer and acute promyelocytic leukemia
Lucijanić, M., Lasan Trčić, R., Kušec, R., Pejša, V., Štoos Veić, T. & Jakšić, O. (2015). Loss of response to azacitidine is associated with deletion 12p13 in a patient with myelodysplastic syndrome with unique translocation t(13;17)(q12;q25) after prior breast cancer and acute promyelocytic leukemia. Annals of Hematology, 94. (9), 1617-1619. doi: 10.1007/s00277-015-2428-6
Lucijanić, Marko, et al. "Loss of response to azacitidine is associated with deletion 12p13 in a patient with myelodysplastic syndrome with unique translocation t(13;17)(q12;q25) after prior breast cancer and acute promyelocytic leukemia." Annals of Hematology, vol. 94, no. 9, 2015, pp. 1617-1619. https://doi.org/10.1007/s00277-015-2428-6
Lucijanić, Marko, Ružica Lasan Trčić, Rajko Kušec, Vlatko Pejša, Tajana Štoos Veić and Ozren Jakšić. "Loss of response to azacitidine is associated with deletion 12p13 in a patient with myelodysplastic syndrome with unique translocation t(13;17)(q12;q25) after prior breast cancer and acute promyelocytic leukemia." Annals of Hematology 94, no. 9 (2015): 1617-1619. https://doi.org/10.1007/s00277-015-2428-6
Lucijanić, M., et al. (2015) 'Loss of response to azacitidine is associated with deletion 12p13 in a patient with myelodysplastic syndrome with unique translocation t(13;17)(q12;q25) after prior breast cancer and acute promyelocytic leukemia', Annals of Hematology, 94(9), pp. 1617-1619. doi: 10.1007/s00277-015-2428-6
Lucijanić M, Lasan Trčić R, Kušec R, Pejša V, Štoos Veić T, Jakšić O. Loss of response to azacitidine is associated with deletion 12p13 in a patient with myelodysplastic syndrome with unique translocation t(13;17)(q12;q25) after prior breast cancer and acute promyelocytic leukemia. Annals of Hematology [Internet]. 2015 September [cited 2024 November 26];94(9):1617-1619. doi: 10.1007/s00277-015-2428-6
M. Lucijanić, R. Lasan Trčić, R. Kušec, V. Pejša, T. Štoos Veić and O. Jakšić, "Loss of response to azacitidine is associated with deletion 12p13 in a patient with myelodysplastic syndrome with unique translocation t(13;17)(q12;q25) after prior breast cancer and acute promyelocytic leukemia", Annals of Hematology, vol. 94, no. 9, pp. 1617-1619, September 2015. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:462231. [Accessed: 26 November 2024]
